As of the latest Form 4 filed Jul 1, 2026.
What IAC Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 34 most recent filings for IAC.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-06-30 | Clinton Chelsea Director | AAward | +135.00 | $46.16 | $6.23K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Lourd Bryan Director | AAward | +352.00 | $46.16 | $16.2K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | EISNER MICHAEL D Director | AAward | +311.00 | $46.16 | $14.4K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Seferian Maria Director | AAward | +271.00 | $46.16 | $12.5K | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Clinton Chelsea Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Braham Tor Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | EISNER MICHAEL D Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Lourd Bryan Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Von Furstenberg Alexander Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Seferian Maria Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | SPOON ALAN G Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | ZANNINO RICHARD F Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | ROSENBLATT DAVID S Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Hammer Bonnie S Director | MExercise | +2.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | ROSENBLATT DAVID S Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Von Furstenberg Alexander Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | SPOON ALAN G Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | ZANNINO RICHARD F Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Lourd Bryan Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Hammer Bonnie S Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Clinton Chelsea Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | EISNER MICHAEL D Director | MExercise | +1.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | ZANNINO RICHARD F Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Seferian Maria Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | ROSENBLATT DAVID S Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Lourd Bryan Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Von Furstenberg Alexander Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | SPOON ALAN G Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Hammer Bonnie S Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | EISNER MICHAEL D Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Clinton Chelsea Director | MExercise | +2.08K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-01 | 2026-05-12 | Schwerdtman Michael H SVP and CAO | SSale | −6.88K | $40.54 | $279K | No | Form 4 ↗ |
| 2026-03-25 | 2026-03-24 | IAC Inc. 10% owner | PPurchase | +450K | $37.13 | $16.7M | No | Form 4 ↗ |
| 2026-03-25 | 2026-03-23 | IAC Inc., 10% owner | PPurchase | +550K | $37.30 | $20.5M | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also IAC’s full analysis or the market-wide insider trading feed. The tabs above jump to IAC’s other SEC data.
Source: SEC Form 4 filings for IAC, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.